Sanner Group has recently acquired Gilero LLC, a medical device design and manufacturing firm based in North Carolina. This strategic move aims to strengthen Sanner's position in the medical device sector and expand its service offerings across drug delivery, diagnostics, and MedTech device sectors.
By integrating Gilero's expertise in design, development, assembly, packaging, and contract manufacturing, Sanner will be able to provide a more comprehensive and integrated service to its clients. This acquisition aligns with Sanner's goal of becoming a leading global provider of customer-specific solutions in the medical technology, diagnostics, pharmaceuticals, and consumer healthcare industries.
With the addition of Gilero, Sanner will enhance its manufacturing and end-to-end capabilities in the United States. This includes expanding its production facilities to include onsite production for desiccant healthcare packaging solutions. The acquisition also allows Sanner to establish an injection molding facility in North Carolina, enabling in-house injection molding services on a global scale.
The acquisition of Gilero also expands Sanner's geographical reach, particularly in key biopharma and MedTech hubs in the United States and Mexico. This expansion opens up opportunities for greater collaboration with partners and helps mitigate global supply chain challenges.
Sanner's acquisition strategy has been supported by a comprehensive advisory team, including financial advisors, tax structuring advisors, and legal counsel. This ensures a well-planned and successful integration of Gilero into Sanner's operations.
This acquisition is a critical step in enhancing Sanner's contract development and manufacturing organization (CDMO) activities on a global scale. It reinforces Sanner's position as a leading global CDMO, further solidifying its ability to provide customer-specific solutions in the medical technology industry.